IDH1 and glioblastoma: In GBM cells, the main forms of IDH are heterodimers containing wild-type IDH1 and R132H mutation monomers, exhibiting neomorphic activity that reduces α-ketoglutarate (α-KG) into D-2-hydroxyglutarate (D-2-HG) with NAPDH consumption and NADP+ production.